Logo image of ALRIB.PA

RIBER SA (ALRIB.PA) Stock Fundamental Analysis

EPA:ALRIB - Euronext Paris - Matif - FR0000075954 - Common Stock - Currency: EUR

3.44  +0.11 (+3.3%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALRIB. ALRIB was compared to 51 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and the financial health of ALRIB get a neutral evaluation. Nothing too spectacular is happening here. ALRIB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ALRIB had positive earnings in the past year.
ALRIB had a positive operating cash flow in the past year.
In the past 5 years ALRIB has always been profitable.
ALRIB had a positive operating cash flow in 4 of the past 5 years.
ALRIB.PA Yearly Net Income VS EBIT VS OCF VS FCFALRIB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

The Return On Assets of ALRIB (8.27%) is comparable to the rest of the industry.
ALRIB has a Return On Equity of 17.48%. This is comparable to the rest of the industry: ALRIB outperforms 58.82% of its industry peers.
The Return On Invested Capital of ALRIB (12.48%) is better than 62.75% of its industry peers.
Industry RankSector Rank
ROA 8.27%
ROE 17.48%
ROIC 12.48%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALRIB.PA Yearly ROA, ROE, ROICALRIB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Profit Margin, with a value of 10.02%, ALRIB is doing worse than 64.71% of the companies in the same industry.
ALRIB's Profit Margin has improved in the last couple of years.
The Operating Margin of ALRIB (10.64%) is worse than 72.55% of its industry peers.
In the last couple of years the Operating Margin of ALRIB has grown nicely.
The Gross Margin of ALRIB (36.08%) is worse than 82.35% of its industry peers.
In the last couple of years the Gross Margin of ALRIB has grown nicely.
Industry RankSector Rank
OM 10.64%
PM (TTM) 10.02%
GM 36.08%
OM growth 3Y33.22%
OM growth 5Y31.15%
PM growth 3Y28.64%
PM growth 5Y25.02%
GM growth 3Y0.64%
GM growth 5Y4.07%
ALRIB.PA Yearly Profit, Operating, Gross MarginsALRIB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALRIB is creating some value.
ALRIB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALRIB.PA Yearly Shares OutstandingALRIB.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
ALRIB.PA Yearly Total Debt VS Total AssetsALRIB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

ALRIB has an Altman-Z score of 3.21. This indicates that ALRIB is financially healthy and has little risk of bankruptcy at the moment.
ALRIB's Altman-Z score of 3.21 is on the low side compared to the rest of the industry. ALRIB is outperformed by 70.59% of its industry peers.
The Debt to FCF ratio of ALRIB is 1.75, which is an excellent value as it means it would take ALRIB, only 1.75 years of fcf income to pay off all of its debts.
ALRIB's Debt to FCF ratio of 1.75 is fine compared to the rest of the industry. ALRIB outperforms 62.75% of its industry peers.
ALRIB has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALRIB (0.07) is better than 82.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.75
Altman-Z 3.21
ROIC/WACC1.11
WACC11.23%
ALRIB.PA Yearly LT Debt VS Equity VS FCFALRIB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

ALRIB has a Current Ratio of 1.58. This is a normal value and indicates that ALRIB is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.58, ALRIB is not doing good in the industry: 72.55% of the companies in the same industry are doing better.
ALRIB has a Quick Ratio of 1.58. This is a bad value and indicates that ALRIB is not financially healthy enough and could expect problems in meeting its short term obligations.
ALRIB has a worse Quick ratio (0.84) than 88.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.84
ALRIB.PA Yearly Current Assets VS Current LiabilitesALRIB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

4

3. Growth

3.1 Past

ALRIB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.06%, which is quite impressive.
ALRIB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.74% yearly.
Looking at the last year, ALRIB shows a small growth in Revenue. The Revenue has grown by 4.82% in the last year.
ALRIB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.20% yearly.
EPS 1Y (TTM)30.06%
EPS 3Y41.89%
EPS 5Y30.74%
EPS Q2Q%-10.09%
Revenue 1Y (TTM)4.82%
Revenue growth 3Y9.68%
Revenue growth 5Y4.2%
Sales Q2Q%1.2%

3.2 Future

ALRIB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.35% yearly.
Based on estimates for the next years, ALRIB will show a small growth in Revenue. The Revenue will grow by 1.90% on average per year.
EPS Next Y-4.76%
EPS Next 2Y2.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.2%
Revenue Next 2Y1.9%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALRIB.PA Yearly Revenue VS EstimatesALRIB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
ALRIB.PA Yearly EPS VS EstimatesALRIB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 0 0.1 -0.1 0.2 -0.2 -0.3

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.20 indicates a rather expensive valuation of ALRIB.
Compared to the rest of the industry, the Price/Earnings ratio of ALRIB indicates a rather cheap valuation: ALRIB is cheaper than 84.31% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, ALRIB is valued a bit cheaper.
A Price/Forward Earnings ratio of 16.70 indicates a correct valuation of ALRIB.
Based on the Price/Forward Earnings ratio, ALRIB is valued a bit cheaper than the industry average as 72.55% of the companies are valued more expensively.
ALRIB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.2
Fwd PE 16.7
ALRIB.PA Price Earnings VS Forward Price EarningsALRIB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALRIB is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALRIB indicates a somewhat cheap valuation: ALRIB is cheaper than 68.63% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 32.75
EV/EBITDA 9.76
ALRIB.PA Per share dataALRIB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.56
EPS Next 2Y2.35%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.29%, ALRIB has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.12, ALRIB pays a better dividend. On top of this ALRIB pays more dividend than 94.12% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, ALRIB has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.29%

5.2 History

The dividend of ALRIB is nicely growing with an annual growth rate of 18.56%!
Dividend Growth(5Y)18.56%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

ALRIB pays out 35.58% of its income as dividend. This is a sustainable payout ratio.
ALRIB's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP35.58%
EPS Next 2Y2.35%
EPS Next 3YN/A
ALRIB.PA Yearly Income VS Free CF VS DividendALRIB.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M -6M
ALRIB.PA Dividend Payout.ALRIB.PA Dividend Payout, showing the Payout Ratio.ALRIB.PA Dividend Payout.PayoutRetained Earnings

RIBER SA

EPA:ALRIB (7/11/2025, 7:00:00 PM)

3.44

+0.11 (+3.3%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)07-23 2025-07-23
Inst Owners0.53%
Inst Owner ChangeN/A
Ins Owners23.64%
Ins Owner ChangeN/A
Market Cap73.10M
Analysts84.44
Price Target3.98 (15.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.29%
Yearly DividendN/A
Dividend Growth(5Y)18.56%
DP35.58%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)25.81%
PT rev (3m)11.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-13.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.86%
Valuation
Industry RankSector Rank
PE 17.2
Fwd PE 16.7
P/S 1.78
P/FCF 32.75
P/OCF 14.66
P/B 3.1
P/tB 3.92
EV/EBITDA 9.76
EPS(TTM)0.2
EY5.81%
EPS(NY)0.21
Fwd EY5.99%
FCF(TTM)0.11
FCFY3.05%
OCF(TTM)0.23
OCFY6.82%
SpS1.94
BVpS1.11
TBVpS0.88
PEG (NY)N/A
PEG (5Y)0.56
Profitability
Industry RankSector Rank
ROA 8.27%
ROE 17.48%
ROCE 16.98%
ROIC 12.48%
ROICexc 18.73%
ROICexgc 26.24%
OM 10.64%
PM (TTM) 10.02%
GM 36.08%
FCFM 5.42%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y33.22%
OM growth 5Y31.15%
PM growth 3Y28.64%
PM growth 5Y25.02%
GM growth 3Y0.64%
GM growth 5Y4.07%
F-Score8
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.75
Debt/EBITDA 0.24
Cap/Depr 115.24%
Cap/Sales 6.69%
Interest Coverage 118.38
Cash Conversion 73.64%
Profit Quality 54.14%
Current Ratio 1.58
Quick Ratio 0.84
Altman-Z 3.21
F-Score8
WACC11.23%
ROIC/WACC1.11
Cap/Depr(3y)112.18%
Cap/Depr(5y)116.77%
Cap/Sales(3y)6.89%
Cap/Sales(5y)7.11%
Profit Quality(3y)540.29%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.06%
EPS 3Y41.89%
EPS 5Y30.74%
EPS Q2Q%-10.09%
EPS Next Y-4.76%
EPS Next 2Y2.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.82%
Revenue growth 3Y9.68%
Revenue growth 5Y4.2%
Sales Q2Q%1.2%
Revenue Next Year-1.2%
Revenue Next 2Y1.9%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.31%
EBIT growth 3Y46.12%
EBIT growth 5Y36.66%
EBIT Next Year47.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-63.28%
FCF growth 3YN/A
FCF growth 5Y-14.36%
OCF growth 1Y-37.51%
OCF growth 3Y42.71%
OCF growth 5Y-5.01%